Compare GPK & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPK | LIVN |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2007 | 2015 |
| Metric | GPK | LIVN |
|---|---|---|
| Price | $9.22 | $64.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $13.08 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 5.6M | 654.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $8,617,000,000.00 | N/A |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | $1.15 | $6.63 |
| P/E Ratio | $6.59 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.79 | $35.00 |
| 52 Week High | $25.81 | $71.58 |
| Indicator | GPK | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 37.09 | 51.58 |
| Support Level | $8.79 | $61.63 |
| Resistance Level | $10.04 | $65.61 |
| Average True Range (ATR) | 0.39 | 1.97 |
| MACD | 0.09 | 0.19 |
| Stochastic Oscillator | 7.30 | 46.32 |
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.